60 day FRN

Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
portal (regulations.gov) or by U.S. mail to the
address listed above.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[60Day–20–0213; Docket No. CDC–2020–
0061]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the National Vital Statistics
Report Forms. This collection is used by
State and/or county vital registration
offices to report to the Federal
government (a) provisional counts of
births, deaths, and infant deaths, at the
end of each month and (b) annual
counts of marriages and divorces/
annulments in support of the National
Vital Statistics System.
DATES: Written comments must be
received on or before August 4, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0061 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:

lotter on DSK9F5VC42PROD with NOTICES

Please note: All public comment should be
submitted through the Federal eRulemaking

VerDate Sep<11>2014

18:21 Jun 04, 2020

Jkt 250001

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:

Centers for Disease Control and
Prevention

Proposed Project
National Vital Statistics Report Forms
(OMB Control No. 0920–0213, Exp. 04/

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

34635

30/2021)—Extension — National Center
for Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The compilation of national vital
statistics dates back to the beginning of
the 20th century and has been
conducted since 1960 by the Division of
Vital Statistics of the National Center for
Health Statistics, CDC. The collection of
the data is authorized by 42 U.S.C. 242k.
This submission requests approval to
collect the monthly and annually
summary statistics for three years.
The Monthly Vital Statistics Report
forms provide counts of monthly
occurrences of births, deaths, and infant
deaths. Similar data have been
published since 1937 and are the sole
source of these data at the National
level. The data are used by the
Department of Health and Human
Services and by other government,
academic, and private research and
commercial organizations in tracking
changes in trends of vital events.
Respondents for the Monthly Vital
Statistics Reports Form are registration
officials in each State and Territory, the
District of Columbia, and New York
City. In addition, local (county) officials
in New Mexico who record marriages
occurring and divorces and annulments
granted in each county of New Mexico
will use this form. This form is also
designed to collect counts of monthly
occurrences of births, deaths, and infant
deaths immediately following the
month of occurrence.
The Annual Vital Statistics
Occurrence Report Form collects final
annual counts of marriages and divorces
by month for the United States and for
each State. These final counts are
usually available from State or county
officials about eight months after the
end of the data year. The data are
widely used by government, academic,
private research, and commercial
organizations in tracking changes in
trends of family formation and
dissolution. Respondents for the Annual
Vital Statistics Occurrence Report Form
are registration officials in each State
and Territory, the District of Columbia,
and New York City.
There are no costs to respondents
other than their time. CDC requests
approval for 175 annual burden hours.

E:\FR\FM\05JNN1.SGM

05JNN1

34636

Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

State, Territory, and New Mexico
County Officials.
State, Territory, and other officials ....

Monthly Vital Statistics Report .........

91

12

8/60

146

Annual Vital Statistics Occurrence
Report.

58

1

30/60

29

Total ...........................................

..........................................................

........................

........................

........................

175

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–12243 Filed 6–4–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[60Day–20–20OT; Docket No. CDC–2020–
0063]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘Mycoplasma genitalium
Treatment Failure Registry.’’ The
purpose of the collection is to determine
which second-line antibiotics are in use
for M. genitalium treatment failure and
monitor antibiotic resistance patterns
for treatment failure cases throughout
the United States.
DATES: CDC must receive written
comments on or before August 4, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0063 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
SUMMARY:

VerDate Sep<11>2014

18:21 Jun 04, 2020

Jkt 250001

Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

Centers for Disease Control and
Prevention

lotter on DSK9F5VC42PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Mycoplasma genitalium Treatment
Failure Registry—New—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division of STD
Prevention requests a three-year
approval of an information collection
request for the Mycoplasma genitalium
Treatment Failure Registry, which will
entail use of a standardized Case Report
Form.
The primary goal of this activity is to
establish a registry to monitor cases of
Mycoplasma genitalium (M. genitalium)
treatment failure in the United States.
The project objectives are as follows: (1)
Using existing clinical data, describe
demographic and behavioral factors
among patients with documented
Mycoplasma genitalium who fail
current CDC-recommended treatment.
(2) Using existing clinical data, describe
antibiotic regimens utilized among
patients with Mycoplasma genitalium
treatment failure, including
documentation of clinical and
microbiologic cure. (3) Using existing
laboratory specimens, monitor genetic
mutations associated with macrolide or
fluroquinolone antibiotic resistance.
Data captured on the standardized Case
Report Form will be analyzed to
determine outcomes from usage of
second-line antibiotic therapy for M.

E:\FR\FM\05JNN1.SGM

05JNN1